Stay updated on Pembrolizumab Post-ASCT in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FIuQCFzRBFuhg5a7PIdQV9uX0FHw.uncropped.jpg&w=3840&q=75)
Latest updates to the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page
- ChecktodayChange DetectedDifference0.7%
- CheckyesterdayNo Change Detected
- Check3 days agoChange DetectedDifference0.7%
- Check4 days agoChange DetectedThe study has been updated to version v2.10.0 and now includes 6 locations, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check5 days agoNo Change Detected
- Check7 days agoChange DetectedDifference0.6%
- Check8 days agoChange DetectedDifference0.7%
- Check10 days agoChange DetectedDifference0.5%
Stay in the know with updates to Pembrolizumab Post-ASCT in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.